Sonoma Pharmaceuticals, Inc. (SNOA)
NASDAQ: SNOA · IEX Real-Time Price · USD
1.000
-0.010 (-1.02%)
At close:
Mar 27, 2023, 3:53 PM
0.985
-0.015 (-1.48%)
After-hours:
Mar 27, 2023, 4:00 PM EDT
SNOA Market Cap
SNOA has a market cap or net worth of $4.65 million as of March 28, 2023. Its market cap has decreased by -42.75% in one year.
Market Cap
4.65M
Enterprise Value
2.50M
1-Year Change
-42.75%
Ranking
Category
Stock Price
$1.00
Market Cap Chart
Since January 25, 2007, Sonoma Pharmaceuticals, Inc.'s market cap has decreased from $92.38M to $4.65M, a decrease of -94.97%. That is a compound annual growth rate of -16.88%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 24, 2023 | 4.65M | 43.84% |
Mar 23, 2023 | 3.23M | -0.95% |
Mar 22, 2023 | 3.26M | -3.67% |
Mar 21, 2023 | 3.39M | 4.81% |
Mar 20, 2023 | 3.23M | -0.95% |
Mar 17, 2023 | 3.26M | - |
Mar 16, 2023 | 3.26M | 6.03% |
Mar 15, 2023 | 3.08M | 1.57% |
Mar 14, 2023 | 3.03M | 3.32% |
Mar 13, 2023 | 2.93M | -1.70% |
Mar 10, 2023 | 2.98M | -4.95% |
Mar 9, 2023 | 3.14M | -5.61% |
Mar 8, 2023 | 3.32M | -0.47% |
Mar 7, 2023 | 3.34M | -3.15% |
Mar 6, 2023 | 3.45M | -1.77% |
Mar 3, 2023 | 3.51M | -7.38% |
Mar 2, 2023 | 3.79M | 4.27% |
Mar 1, 2023 | 3.64M | -4.10% |
Feb 28, 2023 | 3.79M | -8.27% |
Feb 27, 2023 | 4.13M | -1.48% |
Feb 24, 2023 | 4.19M | -4.26% |
Feb 23, 2023 | 4.38M | -2.08% |
Feb 22, 2023 | 4.47M | -0.69% |
Feb 21, 2023 | 4.51M | -3.97% |
Feb 17, 2023 | 4.69M | -3.21% |
View and export this data all the way back to 2007.
Start Free Trial.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Sharps Technology, Inc. | 15.04M |
Applied DNA Sciences, Inc. | 14.20M |
Midatech Pharma plc | 10.11M |
Evoke Pharma, Inc. | 7.52M |
Phio Pharmaceuticals Corp. | 6.77M |
XTL Biopharmaceuticals Ltd. | 6.59M |
Aclarion, Inc. | 6.33M |
Xenetic Biosciences, Inc. | 6.07M |
Kintara Therapeutics, Inc. | 6.05M |
Enveric Biosciences, Inc. | 3.33M |